Cor Vasa 2018, 60(2):245-247

Nová fixní kombinace mezi hypolipidemiky: rosuvastatin plus ezetimib

Published: April 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nová fixní kombinace mezi hypolipidemiky: rosuvastatin plus ezetimib. Cor Vasa. 2018;60(2):245-247.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. A.A. Carter, T. Gomes, X. Camacho, et al., Risk of incident diabetes among patients treated with statins: population based study, British Medical Journal 346 (2013) f2610. Go to original source... Go to PubMed...
    2. T. Kosoglou, P. Statkevich, B. Yang, et al., Pharmacodynamic interaction between ezetimibe and rosuvastatin, Current Medical Research and Opinion 20 (2004) 1185-1195. Go to original source... Go to PubMed...
    3. C.M. Ballantyne, R. Weiss, T. Moccetti, et al., Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study), American Journal of Cardiology 99 (2007) 673-680. Go to original source... Go to PubMed...
    4. H.E. Bays, M.H. Davidson, R. Massaad, et al., Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study), American Journal of Cardiology 108 (2011) 523-530. Go to original source... Go to PubMed...
    5. G.N. Kouvelos, E.M. Arnaoutoglou, M.I. Matsagkas, et al., Effects of rosuvastatin with or without ezetimibe on clinical outcomes in patients undergoing elective vascular surgery: results of a pilot study, Journal of Cardiovascular Pharmacology and Therapy 18 (2013) 5-12. Go to original source... Go to PubMed...
    6. C.M. Ballantyne, R.C. Hoogeveen, J.L. Raya, et al., Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study, Atherosclerosis 232 (2014) 86-93. Go to original source... Go to PubMed...
    7. K. Torimoto, Y. Okada, H. Mori, et al., Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes, Lipids in Health Disease 12 (2013) 137. Go to original source...
    8. R. Saeedi, K. Johns, J. Frohlich, et al., Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients, Lipids in Health and Disease 14 (2015) 57. Go to original source... Go to PubMed...
    9. J. Masuda, T. Tanigawa, T. Yamada, et al., Effect of combination therapy of ezetimibe and rosuvastatin on regression of coronary atherosclerosis in patients with coronary artery disease, International Heart Journal 56 (2015) 278-285. Go to original source... Go to PubMed...
    10. X. Wang, X. Zhao, L. Li, et al., Effects of Combination of Ezetimibe and Rosuvastatin on Coronary Artery Plaque in Patients with Coronary Heart Disease, Heart, Lung and Circulation 25 (2016) 459-465. Go to original source... Go to PubMed...
    11. K.J. Kim, S.H. Kim, Y.W. Yoon, et al., Effect of fixed-dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS-ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe), Cardiovascular Therapeutics 34 (2016) 371-382. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes